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IL-17 production by tissue-resident MAIT cells is locally
induced in children with pneumonia
Bingtai Lu1,2, Ming Liu1,3, Jun Wang1, Huifeng Fan1, Diyuan Yang1, Li Zhang1, Xiaoqiong Gu1, Junli Nie1, Zhenjun Chen4,
Alexandra J. Corbett4, Michael J. Zhan5, Shengbo Zhang6, Vanessa L. Bryant6,7, Andrew M. Lew4,6,7, James McCluskey4, Hai-bin Luo3,
Jun Cui2, Yuxia Zhang1, Yifan Zhan1,6,7 and Gen Lu1
Community-acquired pneumonia (CAP) contributes substantially to morbidity and mortality in children under the age of 5 years. In
examining bronchoalveolar lavages (BALs) of children with CAP, we found that interleukin-17 (IL-17) production was significantly
increased in severe CAP. Immune profiling showed that mucosal-associated invariant T (MAIT) cells from the BALs, but not blood, of
CAP patients actively produced IL-17 (MAIT17). Single-cell RNA-sequencing revealed that MAIT17 resided in a BAL-resident
PLZFhiCD103+MAIT subset with high expression of hypoxia-inducible factor 1α (HIF-1α), reflecting the hypoxic state of the inflamed
tissue. CAP BALs also contained a T-bet+ MAIT1 subset and a novel DDIT3+ (DNA damage-inducible transcript 3-positive) MAIT
subset with low expression of HIF1A. Furthermore, MAIT17 differed from T-helper type 17 (Th17) cells in the expression of genes
related to tissue location, innateness, and cytotoxicity. Finally, we showed that BAL monocytes were hyper-inflammatory and
elicited differentiation of MAIT17. Thus, tissue-resident MAIT17 cells are induced at the infected respiratory mucosa, likely
influenced by inflammatory monocytes, and contribute to IL-17-mediated inflammation during CAP.
Mucosal Immunology (2020) 13:824–835; https://doi.org/10.1038/s41385-020-0273-y
INTRODUCTION
Mucosal-associated invariant T (MAIT) cells are innate T cells that
are abundant in mucosal sites and comprise about 5% of human
blood T cells1. Their semi-invariant T cell receptors (TCRs)
recognize microbial riboflavin metabolite-based antigens pre-
sented on major histocompatibility complex class I-related
protein-1 (MR1)2,3. MAIT cell-deficient MR1−/−mice show impaired
control of bacterial and viral infections with Legionella long-
beachae4, Mycobacterium bovis Bacillus Calmette–Guérin5, Franci-
sella tularensis live vaccine strain6, and influenza A7. There have
been many reports intimating a role of MAIT cells in anti-microbial
immunity in humans. Patients with active tuberculosis5, intensive
care unit-acquired infections8, and HIV infections9,10 have
decreased numbers of MAIT cells in the blood. MAIT cells are
also implicated in the pathogenesis of human diseases11 and
mucosal immune response to bacterial infections12. For example,
Mr1−/− mice showed significantly less gastric pathology during
Helicobacter pylori infection13. It has not been resolved whether
immune defense and immunopathology mediated by MAIT cells
can be distinguished molecularly.
Human MAIT cells are known for their ability to produce
interferon-γ (IFN-γ) and interleukin-17 (IL-17)1, although MAIT cells
at mucosal sites have higher potential for IL-17 production than
their circulating counterparts14–16. In general, molecular and
cellular basis for the tissue difference in IL-17 production by
MAIT cells remains to be unraveled. IL-17 expression by mouse
CD4+ T-helper type 17 (Th17) cells is regulated by certain
transcription factors, including RAR-related orphan receptor γt
(RORγt)17, RORA18, basic leucine zipper ATF-like transcription
factor (BATF)19, and signal transducer and activator of transcrip-
tion 3 (STAT3)20, as well as other factors such as hypoxia-inducible
factor-1 (HIF-1)21 and the aryl hydrocarbon receptor (AhR)22.
Circulating human MAIT cells express RORγt and display a mixed
IFN-γ and IL-17 expression pattern upon in vitro TCR stimulation1.
In individuals with loss-of-function mutations in STAT3 but intact
RORγt expression, MAIT cells have impaired IL-17 expression23.
Overall, the transcriptional machinery governing IL-17 expression
in MAIT cells (MAIT17) and how these cells are induced at mucosal
sites have not been specified.
Community-acquired pneumonia (CAP) is an immune-mediated
lung disease caused by a wide variety of microbial pathogens. As a
substantial cause of morbidity and mortality in children under 5
years of age, CAP remains a major public health burden,
particularly in developing countries24–26. Severe CAP is associated
with acute respiratory and cardiovascular failure, multiple organ
dysfunction, and high mortality27. The proportions of CD4+ T cells
that secrete IL-17A and IL-22 are increased in bronchoalveolar
lavages (BALs) in adult CAP patients compared to healthy
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controls28. The contribution by MAIT cells to IL-17 production and
to CAP (both adult and pediatric) has not been fully defined. We
opine that this may be important, because IL-17 as well as having
a role in defending against infections has been cogently linked to
immunopathology in both mice and humans, including respira-
tory infections29–31.
In this study, we examined the inflammatory mediators at both
systemic and local pulmonary levels in a cohort of children
hospitalized with CAP. We found that BAL IL-17 levels correlated
with disease severity and that MAIT cells in BALs, but not in blood,
were primed for IL-17 production. Bulk RNA-sequencing (RNAseq)
analysis revealed that BAL MAIT cells expressed higher levels of
transcription factors that promote IL-17 production, while blood
MAIT cells expressed higher levels of negative regulators of IL-17
production, like TCF732. Single-cell RNAseq (scRNAseq) showed
that MAIT17 cells are encompassed within a population of cells
with high expression of PLZF, CD103, and HIF-1α. They also
uniquely expressed the pathogenic Th17 marker GPR65, cytotoxic
molecule IL-32, lymphotoxin Β, and granulysin. In addition, BAL
MAIT cells contained two additional subsets: a T-bet+
MAIT1 subset and a novel MAIT subset that expresses the DNA
damage-inducible transcript 3 (DDIT3; also termed CHOP), a pro-
apoptotic transcription factor elicited during endoplasmic reticu-
lum stress. Finally, we showed that BAL monocytes actively
secreted inflammatory cytokines and elicited MAIT17 differentia-
tion. These findings would be consistent with a pathogenetic
pathway whereby pulmonary infection recruits and stimulates
monocytes to promote MAIT17 differentiation during CAP.
RESULTS
Levels of IL-17 and other inflammatory cytokines were higher in
the BALs of children with CAP and corresponded with CAP severity
We recruited 187 hospitalized children with CAP at the Respiratory
Clinic of a tertiary pediatric hospital in Southern China. CAP
severity was classified according to high-resolution computed
tomography (HRCT) scores (HRCT-CAP) ranging from 1 to 6 as
specified in Supplementary Fig. 1A, B. Children with severe CAP
were those who had HRCT scores ≥4. Severe and not-severe (HRCT
scores <4) CAP were defined for 92 and 95 children, respectively
(Supplementary Table 1). Non-CAP control subjects were those
without a concurrent infection but required surgical removal of
inhaled foreign objects. Children with severe CAP had significantly
prolonged fever, cough, and hospitalization. Around 80% of CAP
patients were diagnosed with at least one known pathogen, with
adenovirus and Mycoplasma pneumoniae being the most com-
mon. Infections with multiple pathogens were more common in
children with severe CAP.
We first evaluated the concentrations of inflammatory mediators
in matched plasma and BAL samples from CAP (n= 70) and non-
CAP control subjects (n= 16). Compared with plasma cytokine
concentrations, we found that the concentrations of IL-17A and
IFN-γ were significantly higher in the BALs in children with CAP
(Fig. 1a). Other IL-17-related cytokines, IL-22 and IL-23, measured in
a separate blood and BAL-matched cohort (CAP, n= 27; control,
n= 9) were also significantly elevated in BALs of CAP patients
(Fig. 1b). Levels of several innate cytokines, including those
influencing T cell differentiation (IL-1β, IL-6, IL-12p70) (Fig. 1c)
and chemotaxis (monocyte chemotactic protein-1 [MCP-1], macro-
phage inflammatory protein-1α [MIP-1α], and MIP-1β), were also
significantly higher in the BAL than in the plasma (Fig. 1d).
Compared with BAL in CAP patients, BAL in control subjects had
markedly lower concentrations of most inflammatory mediators.
We then determined whether the levels of BAL inflammatory
mediators corresponded with CAP severity. In an expanded cohort
including unmatched BAL and plasma samples, we found that
compared with BALs of children with non-severe CAP, BALs of
children with severe CAP had significantly increased concentrations
of IL-17A, IFN-γ, IL-1β, and IL-6 (Fig. 1e). Plasma IL-6 was also
significantly higher in severe than in not-severe CAP (Fig. 1f). For
those patients with identifiable pathogens, we did not detect
significant differences between the types of pathogen (whether
adenovirus or Mycoplasma pneumoniae) with the cytokine levels in
the BAL (Fig. 1g). Overall, IL-17 and other inflammatory cytokines
were elevated in CAP BALs, compared with CAP plasma or
control BALs.
MAIT and Th17 cells are prominent sources of IL-17 in the BALs of
children with CAP
To identify the cellular sources of IL-17, we examined the T cell
compartment from CAP patients (110 blood and 100 BAL
samples). MAIT cells were identified by the expression of CD3,
CD161, and reactivity to MR1-5-OP-RU tetramer, or by the
expression of CD3, TCRVα7.2, and CD161. A similar proportion of
MAIT cells was identified with either staining method (Supple-
mentary Fig. 2A), thus affording a level of cross-validation. In
blood, the proportions of MAIT cells within the CD3+ T cell
compartment were significantly lower in CAP patients than those
in control subjects. In contrast, in BAL, this was reversed, that is,
MAIT cell proportions were significantly higher in CAP patients
than in control subjects (Fig. 2a, b). Compared to the control BALs,
the number of MAIT cells was significantly increased in the BALs of
CAP patients (Supplementary Fig. 2B). The abundance of blood
MAIT cells did not significantly alter between acute infection and
at discharge (Supplementary Fig. 2C).
Phenotypically, around 50% of MAIT cells in the BALs of CAP
patients expressed the tissue-resident markers CD69 and CD103,
whereas these markers were barely detectable in blood MAIT cells
of CAP patients or BAL MAIT cells of the controls (Fig. 2c, d). We
further analyzed the CD69 and CD103 expression of MAIT subsets,
and found similar expression levels in the CD8+ and CD8loCD4lo
populations (Supplementary Fig. 2D). For conventional T cells, we
observed reduced CD4+ T and increased CD8+ T cells in the BALs
(Fig. 2a, b). Larger proportions of conventional CD8+ T cells
(median 34%) expressed tissue-resident markers CD69 and CD103
compared to CD4+ T cells (median 7%) in the BALs.
Next, we determined IL-17 expression by BAL T cells. To do this,
we stimulated the cells ex vivo with phorbol myristate acetate
(PMA) and ionomycin. In the BALs of CAP patients, 30% of
MAIT cells and 2% of conventional CD4+ T cells produced IL-17A
(Fig. 2e, f). Although the total number of Th17 cells was more
abundant than the MAIT17 cells, IL-17 was expressed at
significantly increased levels in MAIT17 cells as indicated by the
mean fluorescent intensity (Fig. 2g, h). In contrast, in the blood of
CAP patients, 5% of MAIT cells and <1% of conventional T cells
expressed IL-17A (Fig. 2e, f). Of note, there was a lower frequency
of IFN-γ+ cells in BAL MAIT cells than blood MAIT cells in CAP
patients (Supplementary Fig. 2E, F). In addition, we found that
MAIT cells from control blood contained a high proportion of
IFN-γ+ cells but a low proportion of IL-17A+ cells (Supplementary
Fig. 2G, H). There were no sufficient numbers of MAIT cells from
control BALs for functional evaluation.
Despite the known fact that blood MAIT cell frequencies
increase with age in early life33, the frequency of BAL IL-17A+
MAIT cells significantly declined with age. There was no significant
change in IFN-γ+MAIT cells in CAP patients with increasing age
(Supplementary Fig. 2I). The frequency of IL-17A+ or IFN-γ+ T cell
subsets in BALs did not significantly distinguish between severe
and not-severe CAP (Supplementary Fig. 2J). This was potentially
due to limited study subjects and large age differences. However,
we found that MAIT cells in severe CAP subjects had a significantly
increased IL-17+ to IFN-γ+ ratio when compared to not-severe
CAP (Fig. 2i). Of note, we observed no difference in cytokine
production by T cells, whether the type of pathogen was
adenovirus or mycoplasma (Supplementary Fig. 2K). Together,
MAIT17 skewing may be reflective of immunopathology.
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BAL MAIT cells express high levels of IL-17-related cytokines and
transcription factors
To provide further insight into why blood and BAL MAIT cells
differ in the ability to produce IL-17, we performed bulk RNAseq
using MAIT cells isolated from blood and BALs from five CAP
patients. Compared to blood MAIT cells, BAL MAIT cells
significantly upregulated 483 genes and down-regulated 233
genes (≥2 fold; Fig. 3a and Table S2). At the transcriptional level,
BAL MAIT cells expressed significantly higher levels for IL-17-
related genes, for example, IL17A, CSF2, and IL-21 (p < 0.05;
multivariate power analysis using multivariate analysis of
variance)34 as well as IFNG (Fig. 3b). Among several transcription
factors promoting Th17 differentiation, expression of HIF1A,
AHR, BATF, and STAT3 was significantly higher in BAL MAIT cells
while expression of RORC was not (Fig. 3b). Of note, TCF7, a
transcription factor suppressing Th17 differentiation was highly
expressed in blood MAIT cells (Fig. 3b). Blood and BAL MAIT cells
also showed differences in expression of many genes related to
chemokine/chemokine receptors, T cell activation, and exhaus-
tion (Fig. 3c). In an independent cohort (n= 8), we performed
quantitative polymerase chain reaction (qPCR) to validate
differences on IL-17-related cytokines and regulatory genes.
Compared with blood MAIT cells, BAL MAIT cells from CAP
patients expressed markedly higher levels of IL-17A, IL-17F, and
CSF2 (Fig. 3d) and Th17-promoting transcriptional factors HIF1A,
AHR, and BATF (Fig. 3e). Differences in RORC and STAT3
between blood and BALs were not significant. Among the three
tested Th17-suppressing transcriptional factors, we observed
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Fig. 1 IL-17 and related cytokines are prominently presented in BAL fluids. a, c–g Concentrations of cytokines from plasma and BAL fluid as
determined by Bio-Plex are shown as the range and min to mix boxes with horizontal lines within representing median. a Concentrations of
IL-17A and IFN-γ. Cytokines from paired plasma and BAL samples of CAP (plasma and BAL; n= 70) and non-CAP control subjects (Crl plasma
and Crl BAL; n= 16). b Th17-associated cytokine levels in paired plasma and BAL samples from CAP patients and control subjects (CAP, n= 27;
controls, n= 9). c, d Levels of monocyte-derived cytokines and chemokines. e BAL cytokine levels and disease severity (severe n= 51,
moderate n= 41). f Plasma cytokine levels and disease severity (severe n= 35, moderate n= 35). g Levels of IL-17A or IFN-γ in BAL or plasma
in controls (Crl; n= 16) or in CAP patients infected with adenovirus (ADV; n= 15) or Mycoplasma pneumoniae (MP; n= 14) or both (n= 9).
P values were calculated by paired t test (plasma vs. BAL, a–d) or unpaired t test (CAP vs. control, a–d); unpaired t test (severe vs. moderate,
e, f); and Kruskal–Wallis test for g. NS, not significant.
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significantly decreased expression of TCF7 in BAL MAIT cells
compared with blood (Fig. 3f). PLZF regulates CD103 expres-
sion35; its increase in BAL MAIT cells is consistent with the
finding that IL-17-producing MAIT cells express CD103 (Fig. 3g,
h). Flow cytometric analysis also confirmed higher expression
of chemokine receptors CXCR6, and markers of cell activation
(CD38, CD69, PD-1) by BAL MAIT cells in comparison with blood
MAIT cells from CAP patients (Fig. 3i, j). Although high
expression of CD69 was observed on the surface of BAL
MAIT cells detected by flow cytometry (Fig. 3j), the levels of
CD69 messenger RNA (mRNA) were not upregulated (Fig. 3c).
This discrepancy in protein and mRNA level may be due to the
transient expression and rapid degradation of CD69 mRNA36,37.
Tissue-resident MAIT cells with an IL-17-promoting gene signature
is identified as one of the three subsets of MAIT cells in the BALs
Accumulating evidence indicates that MAIT cells also exhibit
lineage differentiation and functional specialization38. Using ROR-
γt and T-bet reporter mouse models, MAIT1 and MAIT17 cells have
been identified in rodents38. However, alignment with their
human counterparts is not straightforward. We performed
scRNAseq on MAIT cells enriched from the BALs of children with
CAP. MAIT cells were defined by co-expression of TRAV1-2
(TCRVα7.2) and CD161 (Fig. 4a, left panel); 228 high-quality
single-cell transcriptomes of MAIT cells were identified. Using
unsupervised graphic clustering, those cells were partitioned into
three subsets (Fig. 4a, middle and right panel). MAIT17 cells
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expressed Th17-associated genes (IL23R+IL17RA+RORC+RORA+
HIF1A+STAT3+) and the tissue-resident marker CD103; MAIT1 cells,
although also expressing RORC, expressed TBX21/T-bet, STAT4,
and CD8B (Fig. 4b and Supplementary Fig. 4A); and a novel
MAIT subset characterized by high expression of DDIT3 showed
low expression of RORC (Fig. 4b). We also noted that MAIT17 cells
had higher expression of PLZF, a transcription factor that has
been reported to regulate CD103 expression in natural killer
T cells35 (Fig. 4b). Intracellular staining of PLZF protein showed
that MAIT cells, but not conventional T cells, expressed PLZF
(Supplementary Fig. 4B).
Moreover, MAIT17 cells preferentially expressed IL32 and LTB
(lymphotoxin B), and the pathogenic Th17 cell marker GPR6530
(Fig. 4c). MAIT1 cells expressed GRP183, an oxysterol-sensing
molecule involved in cell migration and inflammation39 (Fig. 4c).
Metabolic gene set analysis showed that MAIT17 cells were
enriched in genes encoding glycolysis, oxidative phosphorylation,
and lipid efflux, while the remaining MAIT subsets were enriched
in genes encoding lipid and steroid responses (Fig. 4d). DDIT3+
MAIT cells were characterized by high expression of genes related
to reactive oxygen species (ROS) responses and expression of
genes that would promote cell survival, for example, decrease in
CASP8 and CFLAR (encoding FLIP) (Fig. 4b, d).
As CD4+ Th17 cells were also present in the BALs of pediatric
and adult CAP patients28, we analyzed the functional difference of
MAIT17 and Th17 cells in BAL. Analysis of differentially expressed
genes (DEGs) between MAIT17 and Th17 cells showed that
MAIT17 were PLZF+ and CD103+ in the BAL (Fig. 4e, f). MAIT17
cells also highly expressed characteristic “innateness” markers
from innate lymphocytes (ZBTB16/PLZF, NKG7, KLGR1, NCR3, and
HOPX)40, cytotoxicity (GZMK and PRF1), and chemotaxis CCL4 and
CCL5 (Fig. 4g). In contrast and as expected, Th17 cells expressed T
cell activation-related genes CD40LG, CD5, CD82, LAT, and
TNFRSF1B (Fig. 4g). Differences in transcription factors that
positively regulate IL-17 production were unremarkable between
MAIT and Th17 cells (Fig. 4G), perhaps suggesting functional
convergence under the same inflammatory milieu.
Inflammatory cytokines derived from the BAL CD14+ monocytes
promote pathogenic MAIT17 differentiation
Classically, pathogenic Th17 differentiation is driven by inflamma-
tory cytokines (e.g., IL-1, IL-6, and IL-23) derived from myeloid
cells;29 the BALs contained high levels of such cytokines in CAP
patients (Fig. 1b, c). Hence, we investigated whether monocytic
cells might be responsible for MAIT17 induction. We observed that
CD14+ monocytes, particularly CD14+CD16+ subset were sig-
nificantly enriched in the BALs than in blood (Fig. 5a, b). T-
distributed stochastic neighbor embedding (tSNE) analysis of
concatenate monocytic populations (depleted of granulocytes
and T, B, natural killer (NK) cells) using CD11c, CD14, CD163, BDCA-
4, HLA-DR, CD16, CD86, and FcεRIα parameters revealed that BAL
CD14+ cells showed significantly increased expression of CD16,
HLA-DR, BDCA-4, and CD86 compared with their blood counter-
parts (Fig. 5a, b), indicating a hyper-inflammatory state of the BAL
CD14+ monocytes. Next, bulk RNAseq also revealed higher
expression of IL-17-promoting cytokines in the CD14+ monocytes
in the BALs than in blood (Fig. 5C).
The above findings reveal a possible interaction of BAL
monocytes and the differentiation of MAIT17 cells. We showed
that BAL fluids from CAP patients strongly promoted IL-17
secretion by MAIT and CD4+T cells in vitro upon TCR stimulation
with anti-CD3/CD28, even though the cells were derived from the
blood of normal subjects (Fig. 5D). Of note, IFN-γ production was
not promoted by BAL fluids in T cells (Fig. 5D). To delineate the
possible cytokines in BALs promoting MAIT17 defferentiation, we
added neutralizing antibodies (Abs) to IL-1β and IL-23 to MAIT cell
cultures with BALs. We found that Abs to IL-1β and IL-23 reduced
IL-17A production by MAIT cells upon TCR stimulation
(Supplementary Fig. 4C). Finally, we showed that BAL CD14+
monocytes isolated from BALs of CAP patients directly increased
IL-17 but suppressed IFN-γ production by blood MAIT cells from
healthy subjects (Fig. 5e). Overall, these findings indicate that BAL
CD14+monocytes and their products favored induction of MAIT17
and Th17 in children with CAP. BAL fluid from control patients and
CD14+ monocytes from CAP blood, were less potent to promote
IL-17 production by MAIT cells (Fig. 5f, g).
DISCUSSION
Here we showed that IL-17 level was elevated locally in padiatric
CAP patient and associated with disease severity. Investigation of
IL-17 producers identified that BAL MAIT cells but blood MAIT cells
were the major contributors. Unique expression of several
transcription factors (e.g., HIF1A, BATF, and AHR) that promote
IL-17 production by BAL MAIT cells with high expression of tissue-
resident markers differeniate them from blood counterparts.
ScRNAseq further partitioned BAL MAIT cells into three functional
subsets, including a novel DDIT3+ subset. Finally, we provided
evidence that induction of MAIT17 at the infected respiratory
mucosa is likely the consequence of heightened inflammation,
exemplified with high local concentration of inflammatory
cytokines and monocytes.
Characterization of MAIT cells of blood and BALs showed a
decrease in the abundance of blood MAIT cells in CAP patients
compared to control subjects. This agrees with decreased
numbers of MAIT cells in the blood, observed in patients with
active tuberculosis5, intensive care unit-acquired infections8, and
HIV infections9,10. On the other hand, the frequency of MAIT in the
BAL seems to be more variable. A recent study showed that the
frequencies of MAIT in the BAL of pulmonary tuberculosis patients
were significantly decreased41. In contrast, Lezmi et al.42 reported
that BAL MAIT frequencies were elevated in children with asthma
and MAIT17 was further increased in severe cases. Here we
showed that there was an increase in the abundance of MAIT cells
in CAP BALs over control BALs. We reason that abundance of
MAIT cells at the affected sites could be determined by multiple
factors, such as age, genetics, and disease causes/status. At the
cellular level, abundance of MAIT cells at the affected sites could
also be determined by recruitment, proliferation, and cell death.
These aspects remain to be illustrated.
The cellular and molecular basis for the difference in IL-17
production by blood and tissue MAIT cells is less clear. One
possibility is that functional subsets of MAIT cells may distribute
diversely38,43,44. Interestingly, we also noted that blood MAIT cells,
while lower in IL-17 production, showed “readiness” for IFN-γ
production, as MAIT cells of CAP patients as well as control
subjects contained large proportion of IFN-γ-producing cells upon
stimulation with PMA and ionomycin.
Although MAIT17 also differed from Th17 cells in multiple genes
regulating tissue residency, innateness, and cytotoxicity, key
transcriptional programs that govern IL-17 expression were shared
between MAIT17 and Th17 cells. RORγt is highly expressed by
human MAIT cells1 and typifies MAIT17 cells38. STAT3 is also
required for human MAIT cells to produce IL-17, independent of
RORγt23. Apart from RORγt and STAT3, the BAL MAIT cells of CAP
patients also had robust expression of other Th17-associated
molecules such as AHR, HIF1A, and BATF. Furthermore, we
show that blood MAIT cells of CAP patients expressed higher
levels of TCF7, which has been shown to suppress Th17
differentiation32,45,46. From these findings, one could infer that
blood MAIT cells are less differentiated and that a set of molecular
factors co-ordinate BAL MAIT cells to differentiate into a MAIT17
phenotype.
Our scRNAseq analysis of BAL MAIT cells also revealed a cohort
of MAIT cells with high DDIT3 (CHOP) expression. DDIT3 is a key
player in the ER stress response47. Notably, DDIT3+ MAIT cells
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expressed higher levels of ROS response genes. A recent study
showed that DDIT3 negatively regulates CD8+ T cell responses48.
The functional relevance of DDIT3 expression by the MAIT subset
deserves future investigation.
We suggest that MAIT17 induction is likely promoted by
monocytes activated in situ, that is, BAL monocytes (or their
products in BAL fluid) but not blood monocytes. Our investigation
of BAL myeloid cells revealed that CD14+ monocytes (most with
CD16 expression) highly expressed genes supporting MAIT17 and
Th17 differentiation. A group of cytokines supporting Th17
differentiation is highly expressed by BAL monocytes but not
blood monocytes. We also found that BAL monocytes promoted
differentiation of MAIT17 but suppressed MAIT1. As HIF-1α
suppressed IL-12 production by dendritic cells to hamper Th1
differentiation49, it is interesting to note that BAL monocytes
expressed higher levels of HIF1A. Overall, our findings indicate
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that BAL CD14+ monocytes and their products favored induction
of MAIT17 and Th17. Thus, it is plausible that the highly
inflammatory environment with elevated concentrations of MCP-
1 and MIP-1 α/β could recruit monocytes to the inflammatory
tissues. In turn, accumulated inflammatory monocytes and their
derived cytokines subsequently promote MAIT17 differentiation
locally. Despite the different etiological pulmonary infections
mediating the local activation of monocytes, the overall levels of
IFN-γ and IL-17 and the T cell subsets producing these cytokines
did not significantly change. Although the pathogen-sensing
mechanisms differed at early infection, we speculate that these
infections finally resulted in a similar profile of inflammatory
cytokines, which then shape the adaptive system. Neither
adenovirus nor mycoplasma synthesize riboflavin, the source of
the vitamin-based MAIT cell antigens. Thus, in this setting
MAIT cells were likely activated through commensal microorgan-
isms or co-infecting bacteria in combination with inflammatory
cytokines.
Th17 cells have been suggested to contribute to CAP
pathogenesis in adult patients28. Here we showed that MAIT17
cells are a major contributors of IL-17 in children with CAP,
particularly in early childhood. However, while involvement of
MAIT cells in anti-microbial immunity and pathogenesis of human
diseases is implicated11, direct evidence that MAIT cells mediate
immune defense and immunopathology in human diseases
including CAP is still lacking. Of note, scRNAseq analysis showed
that MAIT17 from CAP patient BAL expressed GRP65. GPR65 is a G
protein-coupled receptor for the glycosphingolipids including
psychosine50. It is considered to be a pathogenic Th17 marker by
promoting excess granulocyte–macrophage colony-stimulating
factor secretion in patients with spondyloarthritis51 and has been
found to regulate Th17 genes30. BAL MAIT17 cells also showed
higher expression of IL-32 and lymphotoxin B, mediators linked to
protection against pathogens and immunopathology52,53.
Together, we speculate that MAIT17 cells at the infection sites
could contribute to pathology. Therefore, these disease-associated
biomarkers may aid to further delineate the role of human
MAIT cells in disease settings.
In summary, MAIT cells are increasingly appreciated as
participants in immune protection and the pathogenesis of human
infectious and non-infectious diseases11. IL-17 production is a
characteristic and yet enigmatic feature of MAIT cells. Here we
demonstrated using multiple approaches that human MAIT17 cells
only become highly functional at the interface of respiratory
infection. The induction of MAIT17 is likely instructed by local
pathogen-activated monocytes and derived cytokines. An unre-
solved issue is whether tissue MAIT17 represents expansion of
local-resident or circulating populations. In either case, induced
MAIT17 cells likely contribute to BAL inflammation and disease
severity in children with CAP. As such, we envisage that pathogenic
MAIT17 may be a propitious target for patients with severe CAP.
METHODS
Ethical clearance
The study was approved by the Medical Ethics Committee of
Guangzhou Women and Children’s Medical Center (2016111853),
and its implementation was according to the International Ethical
Guidelines for Research Involving Human Subjects as stated in the
Declaration of Helsinki. Informed written consent was obtained
from legal guardians of the patients.
Participants
The study was carried out from September 2016 to May 2019 in
187 hospitalized children with CAP who underwent flexible fiber-
optic bronchoscopy for investigation and/or treatment purposes
in a respiratory clinic of the Guangzhou Women and Children’s
Medical Center. CAP severity was classified according to HRCT
scoring system as specified in Supplementary Fig. 1. Non-CAP
control subjects were those without a current infection but
requiring bronchoscopy treatments for removal of inhaled foreign
objects. Control peripheral blood samples were obtained from
age- and sex-matched healthy children who underwent growth
assessments or health checks. Samples from patients and controls
were utilized for analysis of cytokines, cell phenotype, RNAseq,
and scRNAseq as shown in Supplementary Fig. 3.
Flexible bronchoscopy
The criteria of flexible bronchoscopy for CAP children were as
follows: (1) presence of lesions of unknown etiology on the chest
radiography; (2) recurrent pneumonia; (3) persistent pulmonary
infiltrates or consolidation; (4) the need to investigate hemoptysis,
persistent unexplained cough, dyspnea, localized wheeze, or
stridor. BAL was carried out in the most affected area identified
radiologically and/or endoscopically. Warm sterile saline was
instilled at 2–3ml/kg body weight for each affected lobe and
recovered by aspiration into a suction trap under negative
pressure of 6.65–13.3 kPa (50–100 mmHg). BAL recovery rate was
>40%. The BAL samples were collected immediately after flexible
bronchoscopy and stored in 4 °C during transportation.
Pathogen detection
Twenty-one respiratory pathogens were retrieved from the
electronic medical records: mastadenovirus (ADV), bocavirus
(BOV), rhinovirus (RHV), respiratory syncytial virus (RSV), ifluenza
virus A & B (IAV, IBV), parainfluenza virus (PIV), cytomegalovirus
(CMV), enterovirus (EV), Mycoplasma pneumoniae (MP), Moraxella
catarrhalis (MC), Staphylococcus aureus (SA), Streptococcus pneu-
moniae (SP), Acinetobacter baumannii (AB), Haemophilus influenzae
(HI), Stenotrophomonas maltophilia (SM), Pseudomonas aeruginosa
(PA), Klebsiella pneumoniae (KP), Chlamydia pneumoniae (CP),
Candida albicans (CA), and Aspergillus spp. (AS). Pathogen
detection was performed at the central hospital diagnostic
laboratories on blood, throat swab, sputum, or BAL samples.
Bacterial and fungal species were cultured in Bactec9120 auto
microbial culturing hood (BD) for 16–18 h and characterized by
VITEK Compact System (Biomerieux, Marcy-l'Étoile, France). Viral
pathogens were detected by Taqman qPCR54 and/or Pneumoslide
IgM ELISA Kit for ADV, BOV, IAV, IBV, RSV, EV, PIV, RHV MP, and CP
(Vircell, Granada, Spain).
Cytokine assay
Cytokines in plasma and BAL supernatant were measured using
“Bio-Plex Pro™ Human Cytokine Standard 27-Plex, Group I-kit” or
“Bio-Plex Pro™ Human Th17 Cytokine Panel 15-Plex” from BioRad
(Hercules, CA) with magnetic bead-based multiplex immunoassay
(LX1000; Luminex, Austin, TX), according to the manufacturer’s
instructions. For results under the limits of detection, the lowest
value of the standard for each of the cytokines was used for
statistics analysis.
Flow cytometry
Peripheral blood mononuclear cells (PBMCs) were isolated from
venous blood samples by Ficoll density gradient centrifugation.
BAL samples were first filtered through double-layered gauze
before Ficoll centrifugation. Cell pellets from BAL and blood were
washed twice with phosphate-buffered saline (PBS) containing
0.5% bovine serum albumin (BSA) and 0.5 mM ethylenediamine-
tetraacetic acid (EDTA) and stained with various Ab combinations.
For MAIT cell counting, 5 × 105 APC beads (BD Biosciences, San
Jose, CA) were added to the samples before flow cytometry
analyzed. Data were acquired on FACS Aria SORP (BD Biosciences,
San Jose, CA) and analyzed by the Flowjo 10.4 software. Staining
and gating of immune populations were illustrated in the text. Abs
used in this study were CD161 APC, CD3 FITC, MR1-5-OP-RU
tetramer PE, TCRVα 7.2 PE, MR1-6-FP tetramer PE, CD103 BV421,
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CD69 BV510, CD4 BV711, CD8α BV785, IL-17A BV510, IFN-γ PE-Cy7,
IFN-γ FITC, CD45 FITC, CD11c-FITC,HLA-DR BV421, CD16 BV650,
CD86 BV711, CD14 BV785, FcεRIα APC-Cy7,CD163- PE/Dazzle™
594, TCR α/β APC, CD19 APC, TCRVα 7.2 BV421, CD3 BV711, IL-17A
APC-Cy7, and T-bet BV605. All of these Abs were purchased from
BioLegend (San Diego, CA). RORγT PE was purchased from BD
Biosciences. PLZF AF488 was purchased from Thermo Fisher.
Human MR1-5-OP-RU and control MR1-6-FP tetramers have been
previously described3. tSNE was performed on compensated
concatenate populations using default parameters: iterations
1000, Perplexity 20, Eta (learning rate) 200, and Theta 0.5.
Cell stimulation and intracellular staining
PBMCs from BAL or venous blood were cultured on V-bottom 96-
well plates in RPMI-1640 (Gibco) medium (R10) containing 10%
fetal bovine serum (Gibco), 2 mM glutamine (Gibco), 0.05 mM 2-
mercaptoethanol (Sigma-Aldrich), 100 U/ml penicillin/streptomy-
cin (Gibco), and 100 μM non-essential amino acids (Gibco). A
combination of 40 ng/ml phorbol 12-myristate 13-acetate (PMA,
Sigma-Aldrich, St Louis, MO), 1 μM/ml Ionomycin (Sigma-Aldrich),
and 2 μM/ml monensin (Sigma-Aldrich) were used to stimulate the
PBMCs for 4–6 h. Intracellular staining was performed using
eBioscience™ Intracellular Fixation and Permeabilization Buffer
Set (Invitrogen) following the manufacturer’s protocols. Briefly,
stimulated cells were washed with PBS containing 0.5% BSA and
0.5 mM EDTA before being stained with surface markers. Cells
were then washed and fixed at room temperature for 20–30min,
stained for intracellular cytokines permeabilization buffer at 4 °C
for 1 h, and washed with PBS before analysis by flow cytometry.
MAIT differentiation mediated by fluid or monocytes from BAL
T cells were enriched by EasySep™ Human T Cell Isolation Kit
(Stemcell) from PBMCs. MAIT, CD4+ T cells were purified from those
PBMCs by FACS sorting. Ten randomly pooled CAP BAL with a total
50ml volume or 10ml control BAL were concentrated by an
Amicon® Pro Purification System with 10 kDa Amicon® Ultra-0.5
Device (Millipore) to a final volume of 5 or 1 5 × 105 T cells were
cultured in IP10 medium (10% fetal bovine serum+ IMDM (Gibco)
and stimulated with 1:1 anti-CD3/CD28 beads (Gibco). For
differentiation, 0, 5, 10, and 20 μl concentrated BAL fluids (0, 5,
and 10 μl for control BAL) were added to the FACS-sorted T cells. For
CD14+monocyte-MAIT co-culture assays, 105 blood MAIT cells were
cultured with 1 or 2 × 105 FACS-sorted CD14+ monocytes pooled
from BALs or peripheral blood of CAP patients in the presence of
anti-CD3/CD28 beads in IP10 medium for 3 days. For cytokines
neutralization assays, 0, 10, and 20 ng/ml IL-1β (Invivogen) or IL-23
(Mabtech) neutralization Abs were added to 105 blood. MAIT cells
were cultured with anti-CD3/CD28 beads and 10 μl concentrated
BAL fluids in IP10 medium for 3 days (n= 4). Cytokines in the
culture supernatants (IL-17A and IFN-γ) were measured by
LEGENDplex™ bead-based immunoassays (BioLegend).
Bulk RNAseq analysis
The quality of pair-ended raw data was evaluated with fastQC. For
qualified datasets, adaptor trimming was performed with fastp55.
We applied the HISAT-StringTie-Ballgown pipeline for transcript-
level expression analysis56. Briefly, the trimmed reads were
mapped to human genome (hg19) with HISAT2 and the transcript
assembly and quantification were performed with StringTie57. The
R package of ballgown was applied for differential expression
analysis58. Genes with absolute log 2 fold change over 1.0 and
adjusted p value below 0.05 were designated as DEGs.
Isolation of scRNAseq dataset for MAIT and CD4+ T cell subsets
Single-cell transcriptomes for MAIT and CD4+ T cells were isolated
from scRNAseq dataset (GSE124885). Briefly, BAL samples from
five CAP children were mixed for isolation of T cells
(CD45+CD14−CD16−CD3+CD19−), followed by single-cell RNA
library construction (5′ library kit from 10x GENOMICS) and
sequencing on the Illumina HiSeq X Ten platform. After cell
barcoding and reverse transcription, we also split part of the
complementary DNA to enrich TCR transcripts for paired single-
cell TCR-seq [v(d)j sequencing]. Raw data pre-processing was
performed with Cell Ranger v2.1.1 pipeline (10x GENOMICS) with
default setting. The pre-processed 5′ expression data was
analyzed further with the R toolkit Seurat (v.3.0)59. Genes
expressed in <3 cells and cells with <200 genes were removed.
After further filtering, only cells with unique gene counts between
200 and 2500 and percentage of UMI aligning to mitochondrial
genes (%-MT) below 5% were kept. The raw gene expression reads
for each cell were normalized and scaled for dimensional
reduction (principal component analysis) and graph-based clus-
tering (K-nearest neighbor) based on the Euclidean distance in the
space of selected PCs. Uniform manifold approximation and
projection (UMAP) was performed for data visualization. We
annotated each cell cluster based on the expression of canonical
markers. MAIT and CD4+ T cell subsets were isolated from the
whole T cell Seurat object for further analysis. Based on the results
of single-cell TCR-seq, only T cells harboring TRAV1.2 within their
TCRα chain were designated as MAIT cells.
Metabolic gene set expression analysis
Metabolic gene set (Table S4) expression level for each cell were
obtained by running AddModuleScore function within Seurat. The
average gene set expression value for each cluster was scaled
(z-score) among clusters for heat map plotting.
Distance tree plotting
Genes with zero average normalized expression value in each
cluster were removed. The remaining 15,884 genes were used for
Euclidean distance determination and unrooted tree plotting with
R package ape60.
Construction of single-cell trajectories
Single-cell trajectory analysis was performed with the Monocle
package (v.2.8.0) (Trapnell et al.61). The normalized expression
values for MAIT cells were used to create the starting subject
CellDataSet class. The DEGs across cell clusters were identified by
performing a function differential GeneTest (XX [express-
ed_genes,], full Model Formula Str= ‘~cluster’, cores= 1) and
subsequently used as genes to define cell progress. Data
dimensionality was reduced using the DDRTree approach
incorporated in the reduceDimension function. Cells were then
ordered in pseudotime with the orderCells function. The trajectory
was visualized in two-dimensional space by running the
plot_cell_trajectory function in Monocle2.
Quantitative reverse transcription-PCR
Cells were directly reverse-transcribed using Single-Cell Sequence
Specific Amplification Kit (Vazyme, P621-01) according to the
manufacturer’s instructions. Briefly, 1000 flow-sorted MAIT cells
were subjected to a 5 μl PCR reaction mix containing 2.5 μl of 2×
Reaction Mix, 0.5 μl Primer Assay Pool (0.1 μM), and 0.1 μl RT/Taq
enzyme. Primers used in reverse transcription-PCR (RT-PCR) are
shown in Table S5. The reaction mix were quickly freezed in a
−80 °C freezer for 2 min. Quantitative RT-PCR was conducted with
the Applied Biosystems™ QuantStudio™ 6 Flex Real-Time PCR
System, using ChamQ Universal SYBR qPCR Master Mix (Vazyme,
Q711-02). The expression of mRNA encoding detected genes was
normalized relative to that of the mRNA encoding the internal
standard RPL13a (ribosomal protein L13a).
Statistics
Prism 7.0 (GraphPad Software) was used for statistical analysis.
Unpaired t test was used for two groups’ analysis and one-way
analysis of variance for three or more groups’ analysis. Non-
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parametric data were analyzed by Mann–Whitney U test or
Kruskal–Wallis test. For all analyses, two-tailed p values were
calculated. P values for multiple comparisons were adjusted by the
Benjamini-Hochberg method. All data points are shown with
central lines indicating medians, unless stated otherwise.
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